Eilbhe Whelan

Imperial College Healthcare NHS Trust

Papers

1

Total Citations

45

H-Index

1

About

Eilbhe Whelan is a pioneering researcher in metabolomics and cancer diagnostics, with a primary focus on developing innovative mass spectrometry-based screening technologies. Her most cited work introduces laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a transformative metabolomics platform for cervical cancer screening. This breakthrough addresses critical limitations in current triage methods, particularly the challenges posed by high-risk human papillomavirus (hrHPV) testing, which increases sensitivity but also leads to more positive screens requiring effective reflex testing. Whelan’s LA-REIMS approach offers a rapid, label-free alternative to conventional cytology, enabling real-time metabolic profiling of tissue samples to improve diagnostic accuracy. Her research has garnered significant attention, with her flagship paper accumulating 45 citations, underscoring its impact on the field. By bridging analytical chemistry and clinical oncology, Whelan’s work promises to enhance early detection and reduce unnecessary procedures, positioning her as a key contributor to next-generation cancer screening strategies. Her achievements highlight a commitment to translating cutting-edge metabolomics into practical, patient-centered solutions.

Research Focus

Key Achievements

1
H-Index
1
Papers
45
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening
45 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Imperial College Healthcare NHS Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago